Meningococcal immunology.
There is a major need for an effective vaccine against serogroup B disease. The long-term efficacy of the serogroups A, C, Y and W135 conjugate vaccines and the need for booster vaccines has to be determined, as does the effect of changing epidemiology in the United States and worldwide. Control of serogroup A disease in sub-Saharan Africa is a major challenge.
Lepow
Martha L
ML
Division of Infectious Diseases, Department of Pediatrics, Albany Medical Center, Room A-615, Mail Code 24, 47 New Scotland Avenue, Albany, NY 12208, USA. LepowM@mail.amc.edu
Hughes
Patricia A
PA
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control* / Q000821:virology; D022401:Meningococcal Vaccines / Q000008:administration & dosage* / Q000276:immunology; D009345:Neisseria meningitidis / Q000821:virology*; D014481:United States / Q000453:epidemiology
D022401:Meningococcal Vaccines